Replies to post #16393 on Cytodyn Inc (CYDY)

[fred198484]

Combo revenues depends on the label the FDA would give the company. If it is just the salvage market, there will not be many revenues at all. If they allow PRO 140 to be used higher up the chain, the impact could be very, very significant. The label will be another binary event with huge implications for the stock when/if it gets there.